FEB 23, 2016 8:11 AM PST

Vaccine to Fight Opioid Overdose and Addiction

WRITTEN BY: Cassidy Reich
Opioid addiction is a huge problem, with about 2 million Americans suffering from addiction to prescription pain relievers and another approximate half million suffering from heroin addiction. These numbers may seem small compared to the total population of the U.S., but this opioid problem has contributed greatly to drug overdoses becoming the leading cause of accidental death. Of the 47,055 fatal drug overdoses that occurred in 2014, 29,467 of them were a result of some kind of opioid overdose. Deaths due to opioids have been on the rise since the advent of “designer opioids,” such as fentanyl analogs. This trend started back in the 1980s when α-methylfentanyl a.k.a. “China white” hit the scene and caused a surge in fatal overdoses. Fentanyl, a prescription drug that by itself is 10 times more potent than heroin, is very easily synthesized and so there are many fentanyl analogs on the market. Unfortunately, these analogs can be even more potent than fentanyl and they are frequently used to cut heroin, upping the potential for overdoses.

Naloxone is a competitive antagonist with opioids at the μ-opioid receptor and it is capable of reversing an overdose when administered right away. Distributing naloxone kits to those at risk of overdose and their friends and family has helped cut down on deaths due to opioid overdose, but what if there was something that could prevent an overdose from happening in the first place?

Researchers at The Scripps Research Institute have recently published a paper in Angewandte Chemie on their vaccine to combat opioid addiction and overdose. It is an active vaccine that was created by conjugating fentanyl to a larger protein and that complex is what stimulates antibody production. Fentanyl is a small molecule and not capable of eliciting an immune response by itself, so it is called a “hapten.” All of the experiments in this paper were done in mice, but the results are very promising.
 
Vaccine formation and fentanyl structure. For full explanation, see figure 1 in Bremer et al. Angewandte Chemie 2016.

Vaccinated mice were able to handle doses of fentanyl that had a 55% mortality rate in unvaccinated mice. The anti-fentanyl antibodies bind the drug and sequester it in the blood serum. The serum antibodies of the vaccinated mice bound approximately 45 times as much drug as the serum of unvaccinated mice, which translated to less fentanyl reaching the brain of vaccinated mice. Opioids are fatal because they cause respiratory depression/arrest, so if less opioid is reaching the brain, there is a lesser chance of respiratory failure. The vaccine the researchers created and tested generated antibodies against fentanyl and its analogs, but did not cross-react with methadone or oxycodone. This is actually an important point because, for this kind of treatment to be clinically viable, it has to leave some potent pain relievers available for use in case the patient needs surgery or something like that. The main difference between an opioid vaccine and naloxone is that the vaccine is preventative while naloxone is mostly reactive. Naloxone can be used in conjugation with opioids to help wean patients off the drugs, but administering the vaccine could provide the same effect and also help to maintain abstinence.    

Basically, a vaccine for opioid addiction and overdose would help a lot of people and save a lot of lives. Even though this vaccine is still in the early stages of development, I look forwarding to following this line of research because I think it has the potential to go all the way to the clinic.

Sources: Angewandte Chemie, EurekAlert, WHO, and ASAM
About the Author
  • Cassidy is a curious person, and her curiosity has led her to pursue a PhD in Pharmacology at the New York University Sackler Institute of Biomedical Sciences. She likes to talk about science way too much, so now she's going to try writing about it.
You May Also Like
DEC 20, 2020
Microbiology
How Do mRNA Vaccines Work?
DEC 20, 2020
How Do mRNA Vaccines Work?
Scientist Katalin Karikó studied mRNA vaccines for years. She spent years getting grant rejections, but has now helped c ...
DEC 29, 2020
Immunology
Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier
DEC 29, 2020
Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier
Viruses that when administered to patients preferentially attack and kill cancer cells, leaving normal tissues unscathed ...
DEC 24, 2020
Cardiology
The Detrimental Health Impact of Ultra-Processed Foods
DEC 24, 2020
The Detrimental Health Impact of Ultra-Processed Foods
Prepared and highly processed foods have become very common, and they've been linked to negative health effects like obe ...
JAN 06, 2021
Genetics & Genomics
Junk DNA Helps Control the Body Clock
JAN 06, 2021
Junk DNA Helps Control the Body Clock
Our bodies run on a kind of molecular clock, which helps regulate and time certain functions beyond just waking and slee ...
JAN 07, 2021
Clinical & Molecular DX
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
JAN 07, 2021
Breath of Life: Nighttime Respiratory Rates Identify Which Heart Patients Need Surgery
Cardiovascular disease is the leading cause of death worldwide, taking nearly 18 million lives every year. Of these card ...
JAN 13, 2021
Plants & Animals
San Diego Zoo's Gorillas Positive for COVID-19
JAN 13, 2021
San Diego Zoo's Gorillas Positive for COVID-19
Earlier this week, the Associated Press reported that several gorillas at the San Diego Zoo Safari Park tested positive ...
Loading Comments...